Findings

What do systematic reviews say?

188 questions · 201 findings · 54 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 33 · 16.4%GRADE not reported 6 · 3%Very low 39 · 19.4%Low 73 · 36.3%Moderate 42 · 20.9%High 8 · 4%

Summary of findings for the main comparison. Motor imagery vs other therapies (control)

Walking endurance · People performing gait rehabilitation after stroke

1 finding from 1 review

Motor imagery for gait rehabilitation after stroke 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
GRADE not reported

Aerobic exercise and strength training vs usual care

Change from baseline in 6MWT (metres) · children and adults with SMA type 3

1 finding from 1 review

Physical exercise training for type 3 spinal muscular atrophy 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 12 participants
Very low

Rigid dressings vs soft dressings

Physical function ‐ Time from amputation to walking (days) · people who had undergone transtibial amputations

1 finding from 1 review

Rigid dressings versus soft dressings for transtibial amputations 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 56 participants
Very low

Endovascular revascularisation vs no therapy

Maximum walking distance · intermittent claudication

2 findings from 1 review

Endovascular revascularisation versus conservative management for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 125 participants
Moderate
Endovascular revascularisation versus conservative management for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 103 participants
Low

Endovascular revascularisation vs conservative therapy

Pain‐free walking distance · intermittent claudication

2 findings from 1 review

Endovascular revascularisation versus conservative management for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 147 participants
Moderate
Endovascular revascularisation versus conservative management for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 345 participants
Moderate

Endovascular revascularisation plus conservative therapy vs conservative therapy

Maximum walking distance · intermittent claudication

2 findings from 1 review

Endovascular revascularisation versus conservative management for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 432 participants
Moderate
Endovascular revascularisation versus conservative management for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 106 participants
Low

Endovascular revascularisation plus conservative therapy vs conservative therapy

Pain‐free walking distance · intermittent claudication

2 findings from 1 review

Endovascular revascularisation versus conservative management for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 305 participants
Moderate
Endovascular revascularisation versus conservative management for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Endovascular revascularisation vs no therapy

Pain‐free walking distance · intermittent claudication

2 findings from 1 review

Endovascular revascularisation versus conservative management for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 125 participants
Moderate
Endovascular revascularisation versus conservative management for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 103 participants
Low

Endovascular revascularisation vs conservative therapy

Maximum walking distance · intermittent claudication

2 findings from 1 review

Endovascular revascularisation versus conservative management for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 345 participants
Moderate
Endovascular revascularisation versus conservative management for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 184 participants
Moderate

Activity monitor plus other intervention vs other intervention alone

Total time walking (minutes) at end of intervention (< 6 months post‐stroke) · increasing physical activity in adult stroke survivors during inpatient rehabilitation

1 finding from 1 review

Activity monitors for increasing physical activity in adult stroke survivors 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 35 participants
Low

Activity monitor plus other intervention vs other intervention alone

Total time walking (minutes) at end of intervention (> 6 months post‐stroke) · increasing physical activity in adult community dwelling stroke survivors

1 finding from 1 review

Activity monitors for increasing physical activity in adult stroke survivors 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 27 participants
Very low

Stem cell therapy vs any other modality of treatment

Pain‐free walking distance · patients with Buerger's disease

1 finding from 1 review

Stem cell therapy for treatment of thromboangiitis obliterans (Buerger's disease) 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 18 participants
Very low

Intervention not reported

Pain‐free walking distance (m) · adults with intermittent claudication

1 finding from 1 review

Exercise for intermittent claudication 2017 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 391 participants
High

Intervention not reported

Maximum walking distance (m) · adults with intermittent claudication

1 finding from 1 review

Exercise for intermittent claudication 2017 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 500 participants
High

Plasma exchange vs sham exchange or supportive treatment

Walking with aid at 4 weeks · patients with Guillain‐Barré syndrome

Plasma exchange probably leads to higher walking with aid at 4 weeks compared with sham exchange or supportive treatment (moderate certainty).

1 finding from 1 review

Plasma exchange for Guillain‐Barré syndrome 2017 · Cochrane Headline outcomes only
RR 1.6 [1.19, 2.15]
3 studies · 349 participants
Moderate

Circuit class therapy vs other interventions

Six‐minute walk distance · people with stroke

1 finding from 1 review

Circuit class therapy for improving mobility after stroke 2017 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 835 participants
Moderate

Circuit class therapy vs other interventions

Activity Gait speed · people with stroke

1 finding from 1 review

Circuit class therapy for improving mobility after stroke 2017 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 744 participants
Moderate

Circuit class therapy vs other interventions

Balance and mobility Timed up and go test. Standing up, walking, returning to sit down in seconds · people with stroke

1 finding from 1 review

Circuit class therapy for improving mobility after stroke 2017 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 488 participants
Low

Intervention not reported

Age of onset of independent walking (months) · children under six years with cerebral palsy or Down syndrome or at risk of neuromotor delay

1 finding from 1 review

Treadmill interventions in children under six years of age at risk of neuromotor delay 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 58 participants
Moderate

Intervention not reported

Age of onset of walking with assistance (days in study) · children under six years with cerebral palsy or Down syndrome or at risk of neuromotor delay

1 finding from 1 review

Treadmill interventions in children under six years of age at risk of neuromotor delay 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 58 participants
Very low